Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Capman funds in connection with the sale of Proxima
Mandate

Vinge advises Capman funds in connection with the sale of Proxima

May 05, 2011

Vinge has advised funds managed by CapMan in connection with the sale of Proxima. Proxima is a private healthcare provider conducting high quality primary care, diagnostics, specialist care, rehabilitation and occupational healthcare operations. The operations are primarily conducted in the Stockholm although the company also has centres in Uppsala, and the Östergötland and Skåne regions. The transaction is subject to approval by the competent competition authorities.

Vinge’s team consisted of partner Jan Byström together with, among others, associates Martin Hall, Anna-Sofia Nilsson Prevell, Malin Buch and project assistants Pernilla Warg and Mikaela Mars. Partner Marcus Glader provided competition law advice.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025